Company Filing History:
Years Active: 1999
Title: Innovations in Cancer Treatment: The Patents of Sung Sil Lee
Introduction: Sung Sil Lee, an accomplished inventor from Kuri, South Korea, is making strides in the field of cancer treatment. With a keen focus on developing effective therapies, he has secured a patent that showcases his commitment to innovation and improving patient outcomes.
Latest Patents: Lee holds one notable patent for "Anticancer (IV) complexes for oral administration and a method of making." This invention features Platinum (IV) complexes represented by a specific structural formula, where A--A is a symmetrical diamine that can chelate to platinum. The diamines utilized in this complex include ethylene diamine, t(.+-.)-1,2-diaminocyclohexane, 2,2-dimethyl-1,3-propanediamine, cyclohexane-1,1-dimethaneamine, and tetrahydro-4H-pyran-4,4-dimethaneamine. The compound R is notable for being propionyl, butyryl, or valeryl. These compounds are deemed useful in the treatment of cancer, highlighting the significant potential of Lee's research.
Career Highlights: Sung Sil Lee is affiliated with the Korea Institute of Science and Technology, where his work focuses on innovative solutions in medical science. His dedication to research and development in the field of anticancer therapies exemplifies his position as a key figure in contemporary biomedical research.
Collaborations: Lee collaborates with other talented researchers, including Youn Soo Sohn and Young-A Lee, enhancing the potential impact of his work through shared expertise and ideas. This collaboration fosters a creative environment in the pursuit of groundbreaking advancements in cancer treatment.
Conclusion: Sung Sil Lee is a pivotal inventor in the fight against cancer, as evidenced by his significant patent on Platinum (IV) complexes. His contributions, alongside his collaborative efforts at the Korea Institute of Science and Technology, represent a promising frontier in medical innovation. Through his work, Lee is helping to pave the way for more effective and accessible cancer treatments.